Related Experiment Video
Updated: Oct 9, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[New strategies for antiretroviral treatment in HIV infected patients]
1Clinique des Maladies Infectieuses et Tropicales, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75010 Paris, France.
Abstract:
Medical care of HIV-infected patients has been greatly improved during the last four years with the combination of new highly active drugs and routine monitoring of plasma viral load. Three-drugs regimens including a protease inhibitor are the recommended treatments. The objective is the suppression of viral load below detectable levels and the correction of immune deficit. Non-nucleoside reverse transcriptase inhibitors can be used in new therapeutic regimens. To ameliorate efficacy of the antiretroviral treatment and to avoid viral resistance, the tolerance and the ability to adhere are an important challenge.
Related Concept Videos
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Cryptococcal Meningitis

